Table 1.
Physiological variables ([BLa−] and RER) obtained during the HICT and TTE cycling.
| 90% | 95% | 100% | TTE | ||
|---|---|---|---|---|---|
| [BLa−] (mmol.l−1) | SBC2 | 4.71 ± 1.38 | 6.91 ± 1.52 | 8.73 ± 1.80 | 14.09 ± 3.95* |
| SBC3 | 4.30 ± 1.43 | 6.86 ± 1.66 | 9.35 ± 3.68 | 14.87 ± 3.01* | |
| PLA | 4.26 ± 1.43 | 6.79 ± 2.06 | 8.13 ± 2.46 | 11.74 ± 3.47 | |
| RER (AU) | SBC2 | 1.08 ± 0.06 | 1.07 ± 0.04 | 1.08 ± 0.03 | 1.25 ± 0.06* |
| SBC3 | 1.11 ± 0.05 | 1.09 ± 0.06 | 1.09 ± 0.06 | 1.26 ± 0.10* | |
| PLA | 1.08 ± 0.07 | 1.07 ± 0.06 | 1.05 ± 0.04 | 1.15 ± 0.06 |
Data are mean ± SD; HICT, high-intensity, interval cycling test (60 s bouts at 90, 95, and 100% maximal aerobic power); TTE, time to exhaustion; SBC2, 0.2 g.kg−1 BM NaHCO3; SBC3, 0.3 g.kg−1 BM NaHCO3; PLA, sodium chloride (placebo).
*
sig difference compared to PLA (p < 0.05).